Subnormothermic ex vivo lung perfusion attenuates ischemia reperfusion injury from donation after circulatory death donors

被引:10
|
作者
Arni, Stephan [1 ]
Maeyashiki, Tatsuo [1 ]
Opitz, Isabelle [1 ]
Inci, Ilhan [1 ]
机构
[1] Univ Hosp Zurich, Dept Thorac Surg, Zurich, Switzerland
来源
PLOS ONE | 2021年 / 16卷 / 08期
关键词
MACHINE PERFUSION; PROTEIN CARBONYLATION; FUNCTIONAL RECOVERY; PRESERVATION; HIBERNATION; LIVER; HYPOTHERMIA; IMPROVES; OXYGEN; MITOCHONDRIA;
D O I
10.1371/journal.pone.0255155
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Use of normothermic ex vivo lung perfusion (EVLP) was adopted in clinical practice to assess the quality of marginal donor lungs. Subnormothermic perfusion temperatures are in use among other solid organs to improve biochemical, clinical and immunological parameters. In a rat EVLP model of donation after circulatory death (DCD) lung donors, we tested the effect of four subnormothermic EVLP temperatures that could further improve organ preservation. Warm ischemic time was of 2 hours. EVLP time was of 4 hours. Lung physiological data were recorded and metabolic parameters were assessed. Lung oxygenation at 21 degrees C and 24 degrees C were significantly improved whereas pulmonary vascular resistance and edema formation at 21 degrees C EVLP were significantly worsened when compared to 37 degrees C EVLP. The perfusate concentrations of potassium ions and lactate exiting the lungs with 28 degrees C EVLP were significantly lower whereas sodium and chlorine ions with 32 degrees C EVLP were significantly higher when compared to 37 degrees C EVLP. Also compared to 37 degrees C EVLP, the pro-inflammatory chemokines MIP2, MIP-1 alpha, GRO-alpha, the cytokine IL-6 were significantly lower with 21 degrees C, 24 degrees C and 28 degrees C EVLP, the IL-18 was significantly lower but only with 21 degrees C EVLP and IL-1 beta was significantly lower at 21 degrees C and 24 degrees C EVLP. Compared to the 37 degrees C EVLP, the lung tissue ATP content after 21 degrees C, 24 degrees C and 28 degrees C EVLP were significantly higher, the carbonylated protein content after 28 degrees C EVLP was significantly lower and we measured significantly higher myeloperoxidase activities in lung tissues with 21 degrees C, 24 degrees C and 32 degrees C. The 28 degrees C EVLP demonstrated acceptable physiological variables, significantly higher lung tissue ATP content and decreased tissue carbonylated proteins with reduced release of pro-inflammatory cytokines. In conclusion, the 28 degrees C EVLP is a non inferior setting in comparison to the clinically approved 37 degrees C EVLP and significantly improve biochemical, clinical and immunological parameters and may reduce I/R injuries of DCD lung donors.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Sub-Normothermic Ex-Vivo Lung Perfusion Attenuates Ischemia Reperfusion Injury from Donation after Circulatory Death Donors
    Maeyashiki, T.
    Arni, S.
    Iskender, I.
    Weder, W.
    Inci, I.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S237 - S237
  • [2] Lung Transplantation With Donation After Circulatory Determination of Death Donors and the Impact of Ex Vivo Lung Perfusion
    Machuca, T. N.
    Mercier, O.
    Collaud, S.
    Tikkanen, J.
    Krueger, T.
    Yeung, J. C.
    Chen, M.
    Azad, S.
    Singer, L.
    Yasufuku, K.
    de Perrot, M.
    Pierre, A.
    Waddell, T. K.
    Keshavjee, S.
    Cypel, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 (04) : 993 - 1002
  • [3] Subnormothermic Ex Vivo Liver Perfusion (SNEVLP) Reduces Ischemia/Reperfusion Injury in Livers Retrieved after Cardiac Death
    Knaak, J.
    Boehnert, M.
    Spetzler, V.
    Kim, B.
    Louis, K.
    Eid, C.
    Selzner, N.
    Oyedele, A.
    Yip, P.
    Keshavjee, S.
    Grant, D.
    Selzner, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 120 - 120
  • [4] Feasibility of Lung Transplantation From Donation After Circulatory Death Donors Following Portable Ex Vivo Lung Perfusion: A Pilot Study
    Luc, J. G. Y.
    Jackson, K.
    Weinkaur, J. G.
    Freed, D. H.
    Nagendran, J.
    TRANSPLANTATION PROCEEDINGS, 2017, 49 (08) : 1885 - 1892
  • [5] Ex-Vivo Lung Perfusion May Have a Detrimental Impact on Lung Transplants from Donation after Circulatory Death Donors
    Xia, Y.
    Kim, S. T.
    Maloney, J.
    DeCamp, M.
    Lowery, E.
    McCarthy, D.
    Ardehali, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S124 - S124
  • [6] Ex Vivo Lung Perfusion for Circulatory Death Donors in Lung Transplantation
    Halpern, A. L.
    Hirji, S. A.
    Helmkamp, L. J.
    Roberts, S.
    Houk, A. K.
    Okoh, A. K.
    Meguid, R. A.
    Rinewalt, D. E.
    Weyant, M. J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S110 - S111
  • [7] Lung transplantation from donors after circulatory death using portable ex vivo lung perfusion
    Bozso, Sabin
    Vasanthan, Vishnu
    Luc, Jessica G. Y.
    Kinaschuk, Katie
    Freed, Darren
    Nagendran, Jayan
    CANADIAN RESPIRATORY JOURNAL, 2015, 22 (01) : 47 - 51
  • [8] Subnormothermic Ex Vivo Liver Perfusion (SNEVLP) Improves Ischemia/Reperfusion Injury in Livers Retrieved after Cardiac Death.
    Knaak, Jan M.
    Boehnert, Markus U.
    Spetzler, Vinzent N.
    Louis, Kristine S.
    Eid, Corinna
    Selzner, Nazia
    Adeye, Oyedele
    Yip, Paul M.
    Grant, David R.
    Keshafjee, Shaf
    Selzner, Markus
    LIVER TRANSPLANTATION, 2013, 19 : S116 - S116
  • [9] SUBNORMOTHERMIC EX VIVO LIVER PERFUSION (SNEVLP) REDUCES ISCHEMIA/REPERFUSION INJURY IN LIVERS RETRIEVED AFTER CARDIAC DEATH (DCD)
    Knaak, J. M.
    Spetzler, V. N.
    Boehnert, M. U.
    Louis, K. S.
    Eid, C.
    Selzner, N.
    Grant, D. R.
    Levy, G. A.
    Selzner, M.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 5 - 5
  • [10] Cyclosporine A Does Not Mitigate Liver Ischemia/Reperfusion Injury in an Ex Vivo Porcine Model of Donation After Circulatory Death
    Hefler, Joshua
    Hatami, Sanaz
    Thiesen, Aducio
    Wagner, Mitchell J.
    Mainardi, Guilherme
    Himmat, Sayed
    Karvellas, Constantine J.
    Bigam, David L.
    Freed, Darren H.
    Shapiro, A. M. James
    ANNALS OF TRANSPLANTATION, 2024, 29